Exicure (XCUR) Accumulated Expenses (2016 - 2026)
Exicure's (XCUR) quarterly Accumulated Expenses came in at $2.0 million in Q1 2026, down 24.79% YoY from $2.7 million in Q1 2025, and down 8.33% on a QoQ basis from $2.2 million in Q4 2025.
Exicure (XCUR) Accumulated Expenses (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Accumulated Expenses data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Accumulated Expenses fell 24.79% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 24.79% YoY) and the FY2025 annual result came in at $2.2 million, up 7.75% from the prior year.
- Accumulated Expenses slipped to $2.0 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q2 2022 to a low of $836000.0 in Q1 2024.
- A 5-year average of $1.9 million and a median of $2.0 million in 2026 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 80.23% — and 2025, when it jumped 222.81%.
- Tracing XCUR's Accumulated Expenses over 5 years: stood at $1.3 million in 2022, then plunged by 31.22% to $879000.0 in 2023, then soared by 132.08% to $2.0 million in 2024, then advanced by 7.75% to $2.2 million in 2025, then decreased by 8.33% to $2.0 million in 2026.
- The last three Accumulated Expenses figures came in at $2.0 million (Q1 2026), $2.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 846,000.00 |
| Mar 31, 2024 | 836,000.00 |
| Dec 31, 2023 | 879,000.00 |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 3.31 Mn |
| Mar 31, 2022 | 3.23 Mn |
| Dec 31, 2021 | 6.46 Mn |
| Sep 30, 2021 | 5.48 Mn |
| Jun 30, 2021 | 3.23 Mn |